Form DEF 14A CORBUS PHARMACEUTICALS HOLDINGS For: 2 April
#Corbus Pharmaceuticals #DEF 14A #proxy statement #shareholder meeting #executive compensation #director elections #corporate governance
📌 Key Takeaways
- Corbus Pharmaceuticals Holdings filed a DEF 14A proxy statement on April 2.
- The filing outlines matters for shareholder vote at an upcoming meeting.
- It includes details on director elections, executive compensation, and other corporate governance items.
- Shareholders are provided with information to make informed voting decisions.
🏷️ Themes
Corporate Governance, Shareholder Voting
Entity Intersection Graph
No entity connections available yet for this article.